125 related articles for article (PubMed ID: 9838343)
1. Evaluation of ethyl icosapentate in the treatment of hypercholesterolemia in kidney transplant recipients.
Nakamura H; Asano T; Suzuki S; Tokonabe S; Hayakawa M
Transplant Proc; 1998 Nov; 30(7):3047-8. PubMed ID: 9838343
[No Abstract] [Full Text] [Related]
2. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients.
Ghods AJ; Milanian I; Arghani H; Ghadiri G
Transplant Proc; 1995 Oct; 27(5):2579-80. PubMed ID: 7482835
[No Abstract] [Full Text] [Related]
3. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
Cantarell C; Bonal J; Sierra C; Pastor C; Lauzurica R; Capdevila L
Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of treatment with low-dose fluvastatin in hypercholesterolemic renal transplant recipients.
Akiyama T; Ishii T; Imanishi M; Nishioka T; Matsuura T; Kurita T
Transplant Proc; 2001 May; 33(3):2115-8. PubMed ID: 11377469
[No Abstract] [Full Text] [Related]
5. Effect of atorvastatin of the treatment of hypercholesterolemia after renal transplantation.
Alvarez ML; Errasti P; Gómez G; Lavilla FJ; García N; Ballester B; García I; Purroy A
Transplant Proc; 1999 Sep; 31(6):2328-9. PubMed ID: 10500602
[No Abstract] [Full Text] [Related]
6. Effects of cerivastatin on lipid profiles, lipid peroxidation and platelet and endothelial activation in renal transplant recipients.
Caillard S; Leray C; Kunz K; Gachet C; Offner M; Wiesel ML; Hannedouchte T; Cazenave JP; Moulin B
Transplant Proc; 2000 Dec; 32(8):2787-8. PubMed ID: 11134806
[No Abstract] [Full Text] [Related]
7. Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A.
Regazzi MB; Iacona I; Campana C; Gavazzi A; Viganò M; Perani G
Transplant Proc; 1994 Oct; 26(5):2644-5. PubMed ID: 7940825
[No Abstract] [Full Text] [Related]
8. Effect of probucol on hypercholesterolemia in renal transplant patients.
Okubo M; Nakamura M; Horii A; Kamata K; Takeuchi Y; Tsukamoto Y; Kobayashi N; Sato K; Endo T
Kidney Int Suppl; 1999 Jul; 71():S229-30. PubMed ID: 10412784
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum lipid and (APO) lipoprotein levels in renal transplant recipients.
Ishii T; Imanishi M; Nishioka T; Kunikata S; Akiyama T; Kurita T
Transplant Proc; 1998 Nov; 30(7):3021-2. PubMed ID: 9838331
[No Abstract] [Full Text] [Related]
10. Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials).
Mosca L; Ballantyne CM; Bays HE; Guyton JR; Philip S; Doyle RT; Juliano RA
Am J Cardiol; 2017 Feb; 119(3):397-403. PubMed ID: 27939227
[TBL] [Abstract][Full Text] [Related]
11. Hyperlipidemia in stable renal transplant recipients.
Ong-Ajyooth L; Sirisalee K; Shayakul C; Vareesangthip K; Vasuvattakul S; Chirawong P; Vanichakarn S; Nimmannit S; Ong-Ajyooth S; Nilwarangkur S
Transplant Proc; 1994 Aug; 26(4):2062-4. PubMed ID: 8066670
[No Abstract] [Full Text] [Related]
12. Effect of pravastatin in the treatment of hypercholesterolemia after renal transplantation under cyclosporine and prednisone.
Castelao AM; Grinyó JM; Castiñeiras MJ; Fiol C; Gilvernet S; Seron D; Torras J; Cruzado JM; Alsina J
Transplant Proc; 1995 Aug; 27(4):2217-20. PubMed ID: 7652779
[No Abstract] [Full Text] [Related]
13. Lipoprotein abnormalities in renal transplant recipients with chronic vascular rejection.
Dimény E; Fellström B; Larsson E; Tufveson G; Lithell H
Transplant Proc; 1992 Feb; 24(1):366. PubMed ID: 1539319
[No Abstract] [Full Text] [Related]
14. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
[TBL] [Abstract][Full Text] [Related]
15. Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a).
Süleymanlar G; Ozben T; Sapan M; Yìlmaz H; Yakupoglu G; Karpuzoglu T
Transplant Proc; 1994 Oct; 26(5):2637-8. PubMed ID: 7940822
[No Abstract] [Full Text] [Related]
16. Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study).
Bays HE; Braeckman RA; Ballantyne CM; Kastelein JJ; Otvos JD; Stirtan WG; Soni PN
J Clin Lipidol; 2012; 6(6):565-72. PubMed ID: 23312052
[TBL] [Abstract][Full Text] [Related]
17. Comparison of serum lipids, lipoproteins, and fibrinogen in patients with kidney transplantation and hemodialysis.
Demirağ A; Moray G; Ozdemir N; Hizel N; Bilgin N; Haberal M
Transplant Proc; 1998 Aug; 30(5):2052-3. PubMed ID: 9723389
[No Abstract] [Full Text] [Related]
18. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.
Kliem V; Wanner C; Eisenhauer T; Olbricht CJ; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
Transplant Proc; 1996 Dec; 28(6):3126-8. PubMed ID: 8962211
[No Abstract] [Full Text] [Related]
19. Clinical trials of eicosapentaenoic acid (EPA) prescription products for the treatment of hypertriglyceridemia.
Doggrell SA
Expert Opin Pharmacother; 2019 Jul; 20(10):1221-1225. PubMed ID: 31038369
[No Abstract] [Full Text] [Related]
20. The effects of pravastatin on hyperlipidemia in renal transplant recipients.
Yoshimura N; Oka T; Okamoto M; Ohmori Y
Transplantation; 1992 Jan; 53(1):94-9. PubMed ID: 1733092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
